U.S. regulators approved Pfizer’s updated COVID-19 shot Wednesday.
U.S. health officials did not immediately confirm the news but they generally approve updated shots from the nation’s two leading COVID-19 vaccine makers at the same time.
Moderna did not immediately respond to requests for comment.
This year’s updated vaccines target a newer version of the continuously evolving virus and are set to begin shipping immediately. But it could be days or weeks before many Americans know if they’ll be able to get one, with access dependent on various decisions by federal health advisers, private health insurers, pharmacies and state authorities.
The @US_FDA has approved Pfizer and BioNTech SE’s 2025-2026 COVID-19 #vaccine. Learn more about this announcement: https://t.co/DZmuG7iMJ4 pic.twitter.com/5OcN6jamqt
— Pfizer Inc. (@pfizer_news) August 27, 2025